BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...
Hosted on MSN13d
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointedEli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply ...
Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...
Sales of Eli Lilly’s (LLY) blockbuster weight loss drug Zepbound are still booming, but just not at the level Wall Street was ...
Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...
Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the company after long struggling to ...
Eli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply available. The reason for the disappointing sales, according to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback